High incidence of tuberculosis in young children living with HIV in the Western Cape, South Africa.

IF 2.9 3区 医学 Q3 IMMUNOLOGY JAIDS Journal of Acquired Immune Deficiency Syndromes Pub Date : 2025-01-02 DOI:10.1097/QAI.0000000000003591
Kim Anderson, Helena Rabie, Brian S Eley, Lisa Frigati, James Nuttall, Emma Kalk, Alexa Heekes, Mariette Smith, Andrew Boulle, Vanessa Mudaly, Mary-Ann Davies
{"title":"High incidence of tuberculosis in young children living with HIV in the Western Cape, South Africa.","authors":"Kim Anderson, Helena Rabie, Brian S Eley, Lisa Frigati, James Nuttall, Emma Kalk, Alexa Heekes, Mariette Smith, Andrew Boulle, Vanessa Mudaly, Mary-Ann Davies","doi":"10.1097/QAI.0000000000003591","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Data on tuberculosis (TB) incidence and risk factors among children living with HIV (CLHIV) in the universal ART era are limited.</p><p><strong>Methods: </strong>We analysed routinely-collected data on TB diagnoses for CLHIV age ≤5 years, born 2018-2022, in the Westen Cape, South Africa. We examined factors associated with TB diagnosis, with death and loss to follow-up as competing events.</p><p><strong>Results: </strong>Among 2,219 CLHIV, 30% were diagnosed with HIV at birth. Median follow-up from birth was 38 months (IQR 24-50); 90% started antiretroviral therapy (ART). TB was diagnosed in 28% of CLHIV (n=626/2219); 62% were first diagnosed before/within 3 months of ART start ('TB before ART') and 38% >3 months after ART start ('TB after ART'). Of those with 'TB before ART' (n=390), median age at HIV diagnosis was 13 months (IQR:6-22); median time between HIV and TB diagnoses was 5 days (IQR:0-31). 'TB before ART' was associated with older age at HIV diagnosis and advanced/severe immunodeficiency. Of those with 'TB after ART' (n=258), median age at HIV diagnosis was 2 months (IQR 0-8) and median time from ART start to TB diagnosis was 12 months (IQR:7-21). 'TB after ART' was associated with increased viral load and advanced/severe immunosuppression (time-updated). Overall, 5% (n=112/2219) of CLHIV died, 36% of whom were diagnosed with TB (median time from TB diagnosis to death: 58 days; IQR:17-191).</p><p><strong>Conclusions: </strong>Young CLHIV in this setting have high TB-associated morbidity and mortality. Efforts to improve early HIV and TB diagnosis, viral suppression and TB preventive therapy are needed.</p>","PeriodicalId":14588,"journal":{"name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAIDS Journal of Acquired Immune Deficiency Syndromes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/QAI.0000000000003591","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Data on tuberculosis (TB) incidence and risk factors among children living with HIV (CLHIV) in the universal ART era are limited.

Methods: We analysed routinely-collected data on TB diagnoses for CLHIV age ≤5 years, born 2018-2022, in the Westen Cape, South Africa. We examined factors associated with TB diagnosis, with death and loss to follow-up as competing events.

Results: Among 2,219 CLHIV, 30% were diagnosed with HIV at birth. Median follow-up from birth was 38 months (IQR 24-50); 90% started antiretroviral therapy (ART). TB was diagnosed in 28% of CLHIV (n=626/2219); 62% were first diagnosed before/within 3 months of ART start ('TB before ART') and 38% >3 months after ART start ('TB after ART'). Of those with 'TB before ART' (n=390), median age at HIV diagnosis was 13 months (IQR:6-22); median time between HIV and TB diagnoses was 5 days (IQR:0-31). 'TB before ART' was associated with older age at HIV diagnosis and advanced/severe immunodeficiency. Of those with 'TB after ART' (n=258), median age at HIV diagnosis was 2 months (IQR 0-8) and median time from ART start to TB diagnosis was 12 months (IQR:7-21). 'TB after ART' was associated with increased viral load and advanced/severe immunosuppression (time-updated). Overall, 5% (n=112/2219) of CLHIV died, 36% of whom were diagnosed with TB (median time from TB diagnosis to death: 58 days; IQR:17-191).

Conclusions: Young CLHIV in this setting have high TB-associated morbidity and mortality. Efforts to improve early HIV and TB diagnosis, viral suppression and TB preventive therapy are needed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
南非西开普省感染艾滋病毒的幼儿结核病发病率高。
背景:在普遍抗逆转录病毒治疗时代,艾滋病毒(CLHIV)儿童结核病(TB)发病率和危险因素的数据有限。方法:我们分析了南非西开普省2018-2022年出生的CLHIV年龄≤5岁的常规收集的结核病诊断数据。我们将与结核病诊断、死亡和随访损失相关的因素作为竞争事件进行了研究。结果:2219例CLHIV中,30%在出生时被诊断为HIV。出生后的中位随访时间为38个月(IQR 24-50);90%的人开始接受抗逆转录病毒治疗。28%的CLHIV患者被诊断为结核病(n=626/2219);62%在抗逆转录病毒治疗开始前或3个月内首次确诊(“抗逆转录病毒治疗前结核病”),38%在抗逆转录病毒治疗开始后3个月首次确诊(“抗逆转录病毒治疗后结核病”)。在“抗逆转录病毒治疗前患有结核病”的患者中(n=390),诊断出艾滋病毒时的中位年龄为13个月(IQR:6-22);艾滋病毒和结核病诊断之间的中位时间为5天(IQR:0-31)。“抗逆转录病毒治疗前的结核病”与艾滋病毒诊断年龄较大和晚期/严重免疫缺陷有关。在“抗逆转录病毒治疗后结核”患者(n=258)中,艾滋病诊断时的中位年龄为2个月(IQR 0-8),从抗逆转录病毒治疗开始到结核诊断的中位时间为12个月(IQR 7-21)。“抗逆转录病毒治疗后的结核病”与病毒载量增加和晚期/严重免疫抑制(时间更新)有关。总体而言,5% (n=112/2219)的CLHIV患者死亡,其中36%被诊断为结核病(从结核病诊断到死亡的中位时间:58天;差:17 - 191)。结论:在这种情况下,年轻的CLHIV具有较高的结核病相关发病率和死亡率。需要努力改善艾滋病毒和结核病的早期诊断、病毒抑制和结核病预防治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
5.80
自引率
5.60%
发文量
490
审稿时长
3-6 weeks
期刊介绍: JAIDS: Journal of Acquired Immune Deficiency Syndromes​ seeks to end the HIV epidemic by presenting important new science across all disciplines that advance our understanding of the biology, treatment and prevention of HIV infection worldwide. JAIDS: Journal of Acquired Immune Deficiency Syndromes is the trusted, interdisciplinary resource for HIV- and AIDS-related information with a strong focus on basic and translational science, clinical science, and epidemiology and prevention. Co-edited by the foremost leaders in clinical virology, molecular biology, and epidemiology, JAIDS publishes vital information on the advances in diagnosis and treatment of HIV infections, as well as the latest research in the development of therapeutics and vaccine approaches. This ground-breaking journal brings together rigorously peer-reviewed articles, reviews of current research, results of clinical trials, and epidemiologic reports from around the world.
期刊最新文献
Modeling Travel Time to HIV Treatment in Malawi: Identifying Rural-Urban and Wealth Inequities. Trends in the Uptake of Index Testing Among Adolescents in USAID-Supported President's Emergency Plan for AIDS Relief Programs, October 2017-September 2022. Intersecting Structural and Psychosocial Conditions: Investigating Injection Drug Use and HIV Among Transgender Women. Racial and Ethnic Disparities in HIV Diagnosis Rates by Social Determinants of Health at the Census Tract Level Among Adults in the United States and Puerto Rico, 2021. Addressing Methamphetamine Use Is Essential to Stopping HIV Transmission.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1